Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. — CFSMEATLAS
Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lee, Ji-Sook, Lacerda, Eliana M, Nacul, Luis et al. · Frontiers in medicine · 2021 · DOI
Quick Summary
This study tested saliva samples from people with ME/CFS and healthy people to measure levels of common viruses that stay dormant in the body. Researchers found that two viruses (HHV-6B and HHV-7) were present at higher levels in people with ME/CFS, especially in those whose viral levels went up and down over time. Importantly, when these viral levels were higher, patients reported worse symptoms like pain, brain fog, and heart/blood pressure problems.
Why It Matters
For years, researchers have suspected that dormant viruses might play a role in ME/CFS, but couldn't detect them reliably. This study provides the first sensitive molecular evidence linking measurable viral reactivation patterns to specific ME/CFS symptoms, potentially opening new avenues for diagnosis and treatment. The methodology developed here could enable larger studies to clarify whether controlling viral reactivation might improve patient outcomes.
Observed Findings
HHV-6B and HHV-7 DNA loads were significantly higher in saliva samples from ME/CFS patients compared to healthy controls.
ME/CFS patients could be stratified into two groups: those with fluctuating herpesvirus detection patterns over 6 months and those with stable viral patterns.
In patients with fluctuating viral loads, positive correlations existed between HHV-6B and HHV-7 DNA levels and symptom severity scores for pain, neurocognitive dysfunction, and autonomic dysfunction.
Herpes simplex virus 1 and Epstein-Barr virus were also detectable in saliva but at lower frequencies than HHV-6B and HHV-7.
Inferred Conclusions
Herpesvirus reactivation correlates with ME/CFS symptom severity and may contribute to pathogenesis through immune dysregulation.
Fluctuating rather than stable herpesvirus reactivation patterns may define a disease phenotype or severity subgroup in ME/CFS.
Digital droplet PCR applied to saliva sampling is sufficiently sensitive to detect and track herpesvirus reactivation dynamics and warrants larger epidemiological investigations.
Remaining Questions
Does herpesvirus reactivation cause ME/CFS symptoms, or is it a consequence of underlying immune dysregulation in ME/CFS patients?
Would antiviral therapies targeting HHV-6B and HHV-7 reduce symptom severity or disease progression in the fluctuating viral load subgroup?
What This Study Does Not Prove
This study demonstrates correlation, not causation—elevated viral loads may be a cause of ME/CFS symptoms, a consequence of weakened immune control, or both. The small sample size and observational design cannot establish whether antiviral treatments would help patients. The study also does not explain why some ME/CFS patients show stable viral patterns while others show fluctuating patterns.
What mechanisms determine why some ME/CFS patients develop fluctuating viral patterns while others maintain stable viral loads?
Can herpesvirus reactivation patterns and viral loads be used as biomarkers to predict symptom exacerbations or guide personalized treatment strategies?